Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,957Revenue (TTM) $M901Net Margin (%)3.8Altman Z-Score2.9
Enterprise Value $M2,025EPS (TTM) $0.5Operating Margin %11.2Piotroski F-Score5
P/E(ttm)57.6Beneish M-Score-2.7Pre-tax Margin (%)5.9Higher ROA y-yY
Price/Book1.810-y EBITDA Growth Rate %--Quick Ratio2.4Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %-13.4Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow21.9y-y EBITDA Growth Rate %122ROA % (ttm)1.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)3.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M73.9ROIC % (ttm)6.0Gross Margin Increase y-yN

Gurus Latest Trades with IPXL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IPXLJoel Greenblatt 2016-06-30 Add0.09%$28.01 - $36.4
($32.59)
$ 26.49-19%Add 53.33%733,848
IPXLNWQ Managers 2016-06-30 Reduce$28.01 - $36.4
($32.59)
$ 26.49-19%Reduce -2.23%186,406
IPXLJoel Greenblatt 2016-03-31 Add0.16%$30.73 - $42.76
($35.27)
$ 26.49-25%Add 2317.15%478,620
IPXLNWQ Managers 2016-03-31 Reduce-0.01%$30.73 - $42.76
($35.27)
$ 26.49-25%Reduce -3.89%190,660
IPXLNWQ Managers 2015-12-31 Reduce-0.21%$34.53 - $44.76
($40.13)
$ 26.49-34%Reduce -66.75%198,378
IPXLJoel Greenblatt 2015-12-31 Buy 0.01%$34.53 - $44.76
($40.13)
$ 26.49-34%New holding19,801
IPXLNWQ Managers 2015-09-30 Reduce-0.07%$33.27 - $50.42
($45.1)
$ 26.49-41%Reduce -16.00%596,619
IPXLNWQ Managers 2015-06-30 Reduce-0.13%$44.44 - $51.31
($47.45)
$ 26.49-44%Reduce -24.12%710,302
IPXLGeorge Soros 2015-06-30 Sold Out -0.03%$44.44 - $51.31
($47.45)
$ 26.49-44%Sold Out0
IPXLGeorge Soros 2015-03-31 Buy 0.03%$30.2 - $47.3
($39.79)
$ 26.49-33%New holding61,206
IPXLJoel Greenblatt 2015-03-31 Sold Out -0.02%$30.2 - $47.3
($39.79)
$ 26.49-33%Sold Out0
IPXLNWQ Managers 2015-03-31 Add0.02%$30.2 - $47.3
($39.79)
$ 26.49-33%Add 3.32%936,127
IPXLMario Gabelli 2015-03-31 Sold Out -0.0011%$30.2 - $47.3
($39.79)
$ 26.49-33%Sold Out0
IPXLNWQ Managers 2014-12-31 Reduce-0.1%$23.63 - $32.75
($29.3)
$ 26.49-10%Reduce -30.25%906,043
IPXLJoel Greenblatt 2014-12-31 Add0.01%$23.63 - $32.75
($29.4)
$ 26.49-10%Add 136.17%79,609
IPXLMario Gabelli 2014-12-31 Buy $23.63 - $32.75
($29.3)
$ 26.49-10%New holding6,775
IPXLNWQ Managers 2014-09-30 Add0.08%$22.77 - $30.68
($25.55)
$ 26.494%Add 31.90%1,298,995
IPXLJoel Greenblatt 2014-09-30 Buy 0.01%$22.77 - $30.68
($25.55)
$ 26.494%New holding33,709
IPXLNWQ Managers 2014-06-30 Buy 0.3%$23.6 - $30.68
($26.93)
$ 26.49-2%New holding984,841
IPXLJoel Greenblatt 2012-03-31 Sold Out -0.05%$18.64 - $24.37
($20.72)
$ 26.4928%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IPXL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


IPXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BENET LESLIE ZDirector 2016-08-15Sell10,092$22.8116.13view
SCHLOSSBERG MARK ASVP and General Counsel 2015-09-11Sell7,457$43.3-38.82view
NESTOR MICHAELPresident, Impax Pharm. 2015-09-10Sell5,000$43.56-39.19view
FLEMING NIGELDirector 2015-08-31Sell29,166$41.02-35.42view
MARKBREITER MICHAELDirector 2015-08-31Sell28,000$41.7-36.47view
BENET LESLIE ZDirector 2015-08-31Sell20,000$40.92-35.26view
SCHLOSSBERG MARK ASVP and General Counsel 2015-08-27Sell4,649$43.41-38.98view
TERRERI PETER RDirector 2015-08-27Sell4,833$43.93-39.7view
MARKBREITER MICHAELDirector 2015-08-26Sell19,399$42.24-37.29view
HSU LARRYDirector 2014-06-06Sell100,000$28.38-6.66view

Quarterly/Annual Reports about IPXL:

News about IPXL:

Articles On GuruFocus.com
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter Jul 29 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
Alan Fournier Makes Modest Reductions in Middleby and Priceline Jan 12 2016 
Allergan Among Health Care Holdings in Alan Fournier's Portfolio Dec 15 2015 
Pharmaceutical Stocks Hold Prominent Positions in Kyle Bass' 3rd-Quarter Activity Nov 27 2015 
Kyle Bass Goes Fishing for These 3 New Holdings Nov 26 2015 
Alan Fournier's Highest Performing Stocks Jul 15 2015 
Alan Fournier's Most Heavily Weighted Trades In Q1 2015 May 28 2015 
Impax Laboratories Inc. Steps Into Profitable Zone Feb 26 2015 
President and CEO of Impax Laboratories Inc. (IPXL) Larry Hsu Bought 10,000 Shares Aug 17 2011 

More From Other Websites
Impax Launches Generic Version of Metadate CD® (Methylphenidate Hydrochloride Extended-Release... Sep 22 2016
Impax to Present at the Morgan Stanley Global Healthcare Conference Sep 07 2016
Impax Provides Update on Epinephrine Injection, USP Auto-Injector Aug 30 2016
Impax Provides Update on Epinephrine Injection, USP Auto-Injector Aug 30 2016
Impax Laboratories, Inc. Issues Voluntary, Nationwide Recall for One Lot of Lamotrigine Orally... Aug 26 2016
Impax Laboratories, Inc. Issues Voluntary, Nationwide Recall for One Lot of Lamotrigine Orally... Aug 26 2016
ETF’s with exposure to Impax Laboratories, Inc. : August 26, 2016 Aug 26 2016
Why is there no generic EpiPen? Aug 25 2016
Social Sentiment On Mylan Is Nearly Unanimously Negative, And Could Benefit A Competitor Aug 24 2016
Mylan: Five Reasons EpiPen Controversy Won't End Any Time Soon Aug 24 2016
IMPAX LABORATORIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Aug 22 2016
Richard A. Bierly Appointed to Impax Laboratories Board of Directors Aug 22 2016
Richard A. Bierly Appointed to Impax Laboratories Board of Directors Aug 22 2016
IMPAX LABORATORIES INC Financials Aug 18 2016
ETF’s with exposure to Impax Laboratories, Inc. : August 15, 2016 Aug 15 2016
Impax Labs upgraded by Northland Capital Aug 15 2016
Top 6 Companies That Destroyed Shareholders Last Week Aug 14 2016
Impax Laboratories, Inc. :IPXL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 Aug 12 2016
Edited Transcript of IPXL earnings conference call or presentation 9-Aug-16 12:30pm GMT Aug 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)